The "Sysmex Corp (6869) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable ...
(MENAFN- GlobeNewsWire - Nasdaq) The Gene Therapy R&D market presents robust opportunities, driven by clinical advancements in CAR-T therapies and a strong pipeline, particularly for cancer and rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results